Bioequivalence study of two metformin formulations

Arzneimittel-Forschung/Drug Research

Volumn 57, Issue 4, 2007, Pages 192-195

  Al Hawari, Samar ^a   AlGaai, Eman ^a   Yusuf, Ahmed ^a   Abdelgaleel, Abdelraheem ^a   Hammami, Muhammad M ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Antihyperglycaemic agent; Emiphage ; Metformin, bioavailability, bioequivalence, pharmacokinetics

Indexed keywords

EMIPHAGE; METFORMIN; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG HALF LIFE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TABLET;

EID: 34248159984     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296605     Document Type: Article

References (9)

1. Glucophage® Metformin Hydrochloride Product Information. Merck Santé S.A.S and associate of Merck, Darmstadt, Germany. Bristol-Myers Squib Company. July 2002.
2. Hutchinson TA, Shahan DR, eds. Drugdex® System. Greenwood Village, CO, USA: Thomson Micromedex. Edition expired 2004.
3. Najib N, Idkaidek N, Beshtawi M, Bader M, Admour I, Alam S, et al. Bioequivalence Evaluation of two brands of metformin 500 mg tablets (Dialon® & Glucophage®) in healthy human volunteers. Biopharm Drug Dispos. 2002;23(7):301-306.
4. Cheng CL, Chou CH. Determination of metformin in human plasma by liquid chromatography with spectrophotometric detection. J Chromatogr B Biomed Sci Appl. 2001;762(1):51-58.
5. Schuirmann DJ. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm. 1987 Dec;15(6):657-680.
6. Hauschke D, Steinijans VW, Diletti E. A distribution free procedure for the statistical analysis of bioequivalence studies. Int J Clin Pharmacol Ther Toxicol. 1990Feb;28(2): 72-78.
7. Food and Drug Administration. Guidance for Industry: Statistical approaches to establishing bioequivalence. Available at: http://www.fda.gov/ cder/guidance/3616fnl. htm. Accessed January 1, 2006.
8. Xioa CY. Pharmacokinetic study of domestic Metformin tablets in healthy volunteers. Chinese Medical Engineering. 2005 Aug; 13(4):366-368.
9. Health Canada. Guidance for industry: Conduct and analysis of bioavailability and bioequivalence studies - Part B: Oral modified release formulations. Ottawa, Ontario, Canada. Available at http://www.hc-sc.gc.ca/ dhp-mps/prodpharma/applic-demande/guide-ld/bio/bio-b_e.html. Accessed January 1, 2006.